News & Events

In this section

Shanghai Medicilon Chooses Provantis Software Solution

Instem's Software-as-a-Service Model Chosen by one of China's Leading Contract Research Organizations

CONSHOHOCKEN, PA - (BUSINESS WIRE) – June 21, 2011 - - Instem, a leading provider of early development software applications, announced today that Shanghai Medicilon Inc. (Medicilon) has purchased an online subscription to the Provantis® preclinical software solution suite. The purchase incorporates a range of Provantis modules across the areas of general toxicology, clinical pathology and pathology.

Medicilon was founded in 2004 to provide fully integrated services to the global pharmaceutical community. The company’s integrated services across biology, chemistry and preclinical services are specially designed to help their clients develop their research and discovery programs through to IND filings.

Provantis will be used to support preclinical research studies at their 50,000 square feet AAALAC accredited facility in Chuansha Economic Park in Shanghai. The overwhelming standard in western facilities, Provantis offers Medicilon compliance to national and western standards, dual language operation and proven protocol-driven automation that produces high quality study output in greatly reduced timescales.

Commenting on the deal, Dr.Chunlin Chen, Medicilon CEO said “We recognize that Instem is the leader in their field and Provantis will be a strategic tool in helping Medicilon achieve its vision of becoming the top CRO in China providing high quality preclinical drug discovery and development services to global pharmaceutical and biotechnology companies.”

Medicilon will be using Instem’s SaaS (Software-as-a-Service) model offering simpler, more cost effective ways to provide software functionality, maintenance, and support over the Internet. Instem’s Shanghai-based data center meets the highest standards for reliability, security and redundancy and is managed by experienced staff 365 days a year. Strategically located in PuDong, this purpose built data center features a state-of-the-art network, power and environmental infrastructure and is ISO 9001 and SunTone™ certified.

Neil Donaldson, Instem’s VP of Asian and European Operations commented “We are delighted to welcome Medicilon as our latest client in the Asia Pacific region and are looking forward to working with them to support them in their continued high quality service delivery and business growth.”

Instem in the People’s Republic of China (PRC)

As the first western toxicology/pathology software supplier to enter the Chinese market, Instem officially deployed its first China-based system in one of the largest and most advanced vivariums during 2006. Acknowledging analyst projections that by 2014 the PRC would be the second largest pharmaceutical market in the world; Instem established a full-service office in Shanghai, recruited local staff and has localized the Provantis product suite into Mandarin Chinese. Instem is supporting both international organizations and domestic laboratories exclusively serving the PRC.

About Medicilon

Medicilon has been recognized as one of the top drug discovery contract research organizations (CROs) in China and is managed by a team of scientists with many years of experience in US-based pharmaceutical and biotechnology companies. As Medicilon’s areas of expertise and service capabilities continue to expand, major pharmaceutical and biotechnology companies from across 4 continents have taken advantage of their integrated drug discovery and development services.
Medicilon’s headquarters is located in Zhangjiang High-Tech Park in Shanghai, China, with an additional facility in Chuansha Economic Park, Shanghai, China. They occupy over 200,000 square feet of laboratory space and have over 300 employees cross biology, chemistry and preclinical research. Over 50% of Medicilon’s employees have MS and PhD degrees and over 10% have foreign education and/or working experiences.

More info about Medicilon can be found at

About Provantis®

Provantis is a modern, fully integrated software system for single users and global organizations engaged in preclinical evaluation studies. Orchestrating every facet of preclinical drug safety assessment, Provantis streamlines processes and workflows with straightforward, intuitive functionality for simple or complex studies within a GLP or non-GLP environment, on-site or over the Web.

About Instem

Instem is a leading supplier of IT applications to the early development healthcare market, delivering compelling solutions for data collection, management and analysis across the R&D continuum. Instem applications are in use by customers worldwide, meeting the rapidly expanding needs of life science and healthcare organizations for data-driven decision making leading to safer, more effective products.

Instem’s portfolio of software solutions increases client productivity by automating study-related processes while offering the unique ability to generate new knowledge through the extraction and harmonization of actionable scientific information.

Instem supports over 400 clients through full service offices in the United States, United Kingdom and China with additional locations in India and a full service distributor based in Japan.

Meeting clients at the intersection of investment & return™.

Press Contacts:

Gary Mitchell (US HQ)
Tel: 610-941-0990

Julie Jones (UK HQ)
Tel: +44 (0) 1785 825600